These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9159016)

  • 1. Polysensitivity and familiar occurrence in fixed drug eruption.
    Bhargava P; Kuldeep CM; Mathur NK
    Int J Dermatol; 1997 Mar; 36(3):236. PubMed ID: 9159016
    [No Abstract]   [Full Text] [Related]  

  • 2. Fixed drug eruption due to multi-vitamin multi-mineral preparation as part of familial polysensitivity.
    Gulati R; Bhargava P; Mathur NK
    J Assoc Physicians India; 1999 Feb; 47(2):253. PubMed ID: 10999109
    [No Abstract]   [Full Text] [Related]  

  • 3. Informing the patient.
    Jetty KR; Sidebottom A
    Br Dent J; 2013 Jun; 214(12):607. PubMed ID: 23787835
    [No Abstract]   [Full Text] [Related]  

  • 4. Fixed drug eruption due to tipepidine hibenzate and garenoxacin mesylate hydrate: an unusual case of polysensitivity.
    Harada Y; Fukuda H
    Eur J Dermatol; 2024 Feb; 34(1):104-105. PubMed ID: 38557473
    [No Abstract]   [Full Text] [Related]  

  • 5. Fixed drug eruption due to norfloxacin with cross-reactivity to ciprofloxacin: A case report.
    Alpalhão M; Antunes J; Soares-Almeida L; Correia TE; Filipe P
    Contact Dermatitis; 2020 Aug; 83(2):135-137. PubMed ID: 32243605
    [No Abstract]   [Full Text] [Related]  

  • 6. Fixed drug eruption induced by ciprofloxacin and cross-reactivity to other quinolones.
    Garnica Velandia DR; Dalmau Duch G; Gázquez García V; Indiveri M; Gaig Jané P
    Contact Dermatitis; 2017 Oct; 77(4):261-262. PubMed ID: 28872202
    [No Abstract]   [Full Text] [Related]  

  • 7. A case report of fixed drug eruption caused by several drugs because of cross-reactivity and co-sensitization.
    Sobrino-García M; Gómez-Cardeñosa A; Moreno-Rodilla E; Muñoz-Bellido FJ; Lázaro-Sastre M; Dávila I
    Contact Dermatitis; 2019 Jan; 80(1):56-57. PubMed ID: 30246872
    [No Abstract]   [Full Text] [Related]  

  • 8. Fixed drug eruption in a mother and her son.
    Hatzis J; Noutsis K; Hatzidakis E; Bassioukas K; Perissios A
    Cutis; 1992 Jul; 50(1):50-2. PubMed ID: 1387603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fixed drug eruption induced by phenylephrine: a case of polysensitivity.
    López Abad R; Iriarte Sotés P; Castro Murga M; Gracia Bara MT; Sesma Sánchez P
    J Investig Allergol Clin Immunol; 2009; 19(4):322-3. PubMed ID: 19639731
    [No Abstract]   [Full Text] [Related]  

  • 10. Independent lesions of fixed drug eruption caused by trimethoprim-sulfamethoxazole and tenoxicam in the same patient: a rare case of polysensitivity.
    Ozkaya-Bayazit E
    J Am Acad Dermatol; 2004 Aug; 51(2 Suppl):S102-4. PubMed ID: 15280825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fixed drug eruption due to norfloxacin and cross-reactivity with other quinolones.
    Sánchez-Morillas L; Rojas Pérez-Ezquerra P; González Morales ML; Mayorga C; González-Mendiola R; Laguna Martínez JJ
    Allergol Immunopathol (Madr); 2013; 41(1):60-1. PubMed ID: 22266146
    [No Abstract]   [Full Text] [Related]  

  • 12. Fixed drug eruption with vancomycin.
    Joshi PP; Ahmed N
    Ann Pharmacother; 2002 Jun; 36(6):1104. PubMed ID: 12058705
    [No Abstract]   [Full Text] [Related]  

  • 13. Doxycycline-induced fixed drug eruption.
    Gul U; Gonul M; Soylu S; Kaya I
    J Dermatolog Treat; 2008; 19(2):126-7. PubMed ID: 18484432
    [No Abstract]   [Full Text] [Related]  

  • 14. Fixed drug eruption from clarithromycin.
    Rosina P; Chieregato C; Schena D
    Contact Dermatitis; 1998 Feb; 38(2):105. PubMed ID: 9506224
    [No Abstract]   [Full Text] [Related]  

  • 15. Patch testing in fixed drug eruptions--a 20-year review.
    Andrade P; Brinca A; Gonçalo M
    Contact Dermatitis; 2011 Oct; 65(4):195-201. PubMed ID: 21702758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fixed drug eruption probably induced by azithromycin.
    An I; Demir V; Akdeniz S
    Australas J Dermatol; 2017 Nov; 58(4):e253-e254. PubMed ID: 28726337
    [No Abstract]   [Full Text] [Related]  

  • 17. Irreversible nephrotoxicity from demeclocycline in the treatment of hyponatremia.
    Curtis NJ; van Heyningen C; Turner JJ
    Age Ageing; 2002 Mar; 31(2):151-2. PubMed ID: 11937482
    [No Abstract]   [Full Text] [Related]  

  • 18. No association between HLA-B and cutaneous reactions to sulphonamides in human immunodeficiency virus-infected patients.
    Vitezica ZG; Wolkenstein P; Lonjou C; Eliaszewicz M; Sicard X; Roujeau JC; Hovnanian A
    Br J Dermatol; 2008 Aug; 159(2):501-3. PubMed ID: 18547316
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug eruptions and anaphylactic reactions at a Finnish central hospital].
    Ohela K; Ahonen A
    Duodecim; 1972; 88(19):1177-84. PubMed ID: 4262843
    [No Abstract]   [Full Text] [Related]  

  • 20. Polysensitivity in fixed drug eruption due to a novel drug combination-independent lesions due to piroxicam and cotrimoxazole.
    Ozkaya E
    Eur J Dermatol; 2006; 16(5):591-2. PubMed ID: 17101493
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.